Corticorelin

Summary

Corticorelin (CHEMBL2108182) is a phase-3 clinical-stage protein (ATC V04CD04).

At a glance

• Status: Max clinical phase 3 (not approved)
• Modality: Protein
• ATC class: V04CD04
• Clinical trials: 4

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL2108182
Name	Corticorelin
Type	Protein
Max phase	3
ATC	V04CD04

Also known as: Corticoliberin human, Corticorelin, Corticorelin (human), Corticorelin human, Corticorelina, Corticoreline, Corticotropin-releasing factor, Corticotropin-releasing hormone, Crf, Human corticoliberin, NEU-3002, CORTICORELIN

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indications (0 at ChEMBL trial phase 4).

Clinical trials

Total trials: 4.

Phase distribution

Phase	Trials
Not specified	3
PHASE1	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT03142893	PHASE1	ACTIVE_NOT_RECRUITING	Hormonal Mechanisms of Sleep Restriction - Axis Study
NCT01984177	Not specified	COMPLETED	Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence
NCT03628482	Not specified	COMPLETED	Pulsed Radiofrequency to Relieve Knee Pain
NCT06391515	Not specified	COMPLETED	Subacute Thyroiditis in the SARS-CoV-2 Era

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).